¼¼°èÀÇ ½ÉÀåÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ÄÄÆ÷³ÍÆ®º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2024-2031³â)
Global Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report By Component (Services, Software, and Hardware), By End-use, By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1709786
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,085,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,102,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,542,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÉÇ÷°ü µðÁöÅÐ °Ç°­ ¼¼°è ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 21.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 1,624¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶ÇÇÑ, ½º¸¶Æ®¿öÄ¡, ÇÇÆ®´Ï½º Æ®·¡Ä¿, ¿þ¾î·¯ºí ½ÉÀüµµ ¸ð´ÏÅÍ µî ¿þ¾î·¯ºí ±â±â´Â Áö³­ 10³â°£ ºñ¾àÀûÀÎ ¼ºÀåÀ» °ÅµìÇÏ¸ç ¿¹¹æÀû ½ÉÇ÷°ü °ü¸®¿¡ ÇʼöÀûÀÎ µµ±¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â°¡ ½ÉÀå °Ç°­¿¡ º¯È­¸¦ °¡Á®¿Â ´ëÇ¥ÀûÀÎ »ç·Ê Áß Çϳª´Â ½É¹æ¼¼µ¿(AFib)À» °¨ÁöÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î, AFib´Â ºÒ±ÔÄ¢ÇÏ°í ºó¸ÆÀÌ ÀÖ´Â ½ÉÀå ¹Úµ¿ ¸®µëÀ¸·Î ½ÉºÎÀü, ³úÁ¹Áß, Ç÷Àü ¹× ±âŸ ½ÉÀå °ü·Ã ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀåÄ¡´Â ¿¹¹æ ½ÉÀåÇÐ ¹× ¸¸¼º Áúȯ °ü¸®¿¡ ´õ¿í Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶ÇÇÑ, Äڷγª19 ÆÒµ¥¹ÍÀº Ãʱ⿡ ¼øÈ¯±â µðÁöÅÐ Çコ ½ÃÀå¿¡ ¸î °¡Áö µµÀüÀ» ¾È°ÜÁÖ¾ú½À´Ï´Ù. Ãʱ⿡´Â Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ Äڷγª19 È®ÁøÀÚ ±ÞÁõÀ¸·Î ÀÎÇØ ºñÀÀ±Þ ¼øÈ¯±â Áúȯ Ä¡·á¿¡ ´ëÇÑ °ü½É°ú ÀÚ¿øÀ» »©¾Ñ±â¸é¼­ Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ¾Ðµµ´çÇß½À´Ï´Ù. ½ÉÀ庴 ȯÀÚÀÇ ¼±ÅÃÀû Ä¡·á¿Í Á¤±â °ËÁøÀº Á¾Á¾ ¿¬±âµÇ°Å³ª ÁߴܵǾî Ç¥ÁØ Ä¡·á ¹× ¸ð´ÏÅ͸µ ÇÁ·Î¼¼½º¿¡ ÁöÀåÀ» ÃÊ·¡Çß½À´Ï´Ù. µû¶ó¼­ Àü¿°º´Àº Àüü ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

±×·¯³ª ¿þ¾î·¯ºí ½ÉÀüµµ ¸ð´ÏÅÍ, AI ±â¹Ý Áø´Ü, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº ÀåÄ¡´Â °í°¡À̱⠶§¹®¿¡ ¸¹Àº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í ȯÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Áö¼ÓÀûÀÎ ¾÷µ¥ÀÌÆ®, ¼ÒÇÁÆ®¿þ¾î ÅëÇÕ, Ŭ¶ó¿ìµå ½ºÅ丮Áö¸¦ ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â ¿î¿µ ºñ¿ë Áõ°¡·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á ÀÎÇÁ¶ó¸¦ ±¸ÃàÇÏ°í ¼øÈ¯±â Áúȯ ȯÀÚ¸¦ À§ÇÑ µðÁöÅÐ Ç÷§ÆûÀ» À¯ÁöÇÏ·Á¸é »çÀ̹ö º¸¾È, ±ÔÁ¦ Áؼö, Á÷¿ø ±³À°¿¡ ´ëÇÑ ÅõÀÚ°¡ ÇÊ¿äÇϸç, ÀÌ´Â ÀÇ·á ±â°ü¿¡ ÀçÁ¤Àû ºÎ´ãÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ Àü·«Àû °³ÀÔÀÌ ¾ø´Ù¸é, µðÁöÅÐ Çコ ÅøÀÇ ³ôÀº ºñ¿ëÀº µðÁöÅÐÈ­¸¦ ÅëÇÑ ¼øÈ¯±â °Ç°­°ü¸® Çõ½Å¿¡ Å« °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ºÎǰ Àü¸Á

½ÃÀåÀº ±¸¼º ¿ä¼Ò¿¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î, ¼­ºñ½º·Î ºÐ·ùµË´Ï´Ù. Çϵå¿þ¾î ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 29%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÀüµµ ¸ð´ÏÅÍ, ½É¹Ú¼ö ¼¾¼­°¡ ÀåÂøµÈ ½º¸¶Æ® ¿öÄ¡, À̽ÄÇü ½ÉÀå ÀåÄ¡¿Í °°Àº ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä´Â ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº ȯÀÚ, ÀÇ·á Á¦°ø¾÷ü, ÁöºÒÀÚ ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. ÀÇ·á Á¦°ø¾÷ü ºÎ¹®Àº 2023³â ½ÃÀå ¸ÅÃâ Á¡À¯À²ÀÇ 21%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º´¿ø, Áø·á¼Ò, ½ÉÀå¼¾ÅÍ¿¡¼­´Â ¿ø°Ý ÀÇ·á Ç÷§Æû, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, AI¸¦ Ȱ¿ëÇÑ Áø´Ü ¼Ö·ç¼Ç°ú °°Àº µðÁöÅÐ Çコ ÅøÀ» µµÀÔÇÏ¿© Àû½Ã¿¡ Á¤È®ÇÑ ½ÉÇ÷°ü Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA(¶ó ¸Þ¸®¾Æ, ¶ó ¸Þ¸®¾Æ) µî 4°³ Áö¿ªÀ¸·Î ½ÃÀåÀ» ºÐ¼®Çß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2023³â ½ÃÀå ¼öÀÍÀÇ 24%¸¦ Â÷ÁöÇß½À´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ­, ½Ä½À°üÀÇ º¯È­, ÁÂ½Ä »ýȰ½À°ü, °íÇ÷¾Ð°ú ´ç´¢º´ÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ½ÉÀ庴 ¿¹¹æ ¹× °ü¸®¸¦ À§ÇÑ µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå °æÀï ºÐ¼® - ¼¼°è

Á¦5Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦6Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå : Áö¿ªº°

Á¦8Àå ±â¾÷ °³¿ä

Á¦9Àå ½ÉÀåÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå ÇÊ ¼ö¿ä°Ç

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Digital Health For Cardiovascular Market size is expected to reach $162.40 billion by 2031, rising at a market growth of 21.9% CAGR during the forecast period.

The North America segment witnessed 37% revenue share in the market in 2023. The region benefits from the widespread use of remote patient monitoring (RPM) devices, telemedicine platforms, and wearable health technologies like the Apple Watch and KardiaMobile, which are FDA-cleared for detecting cardiovascular conditions such as atrial fibrillation.

The global prevalence of cardiovascular diseases (CVDs) has been rising at an alarming rate, making them the leading cause of death worldwide. In 2019, the World Health Organization (WHO) estimated that 17.9 million individuals perished from cardiovascular diseases (CVDs), which accounted for 32% of all global deaths. Heart attacks and strokes were responsible for 85% of these fatalities. Hence, the rising prevalence of cardiovascular diseases globally drives demand for digital health solutions.

Additionally, Wearable devices such as smartwatches, fitness trackers, and wearable ECG monitors have grown significantly over the past decade, emerging as vital tools in proactive cardiovascular care. One of the standout examples of wearables transforming heart health is their ability to detect atrial fibrillation (AFib). AFib is a cardiac rhythm that is irregular and frequently rapid, and it can result in heart failure, stroke, blood clots, and other heart-related complications. Thus, as technology advances, these devices are expected to become an even more integral part of preventive cardiology and chronic disease management.

Moreover, The COVID-19 pandemic initially posed several challenges to the digital health for cardiovascular market. In the early stages, healthcare systems worldwide were overwhelmed by COVID-19 cases, diverting attention and resources from non-emergency cardiovascular care. Elective procedures and routine check-ups for heart patients were often delayed or canceled, disrupting the standard treatment and monitoring processes. Thus, the pandemic had an overall positive impact on the market.

However, Many healthcare providers and patients are unable to access devices such as wearable cardiac monitors, AI-powered diagnostics, and remote patient monitoring systems due to their substantial cost. These technologies often require continuous updates, software integrations, and cloud storage, increasing operational expenses. Additionally, setting up telemedicine infrastructure and maintaining digital platforms for cardiovascular patients demands investment in cybersecurity, compliance with regulations, and staff training, which can financially overwhelm healthcare institutions. Hence, without strategic interventions, the high cost of digital health tools will continue to be a significant hurdle in transforming cardiovascular healthcare through digitalization.

Driving and Restraining Factors

Drivers * Rising Prevalence of Cardiovascular Diseases (CVDs)

Restraints * High Cost of Advanced Digital Health Tools

Opportunities * Technological Advancements in Telehealth

Challenges * Regulatory and Reimbursement Challenges

Component Outlook

Based on component, the market is classified into software, hardware, and services. The hardware segment procured 29% revenue share in the market in 2023. The demand for devices such as ECG monitors, smartwatches with heart rate sensors, and implantable cardiac devices has increased as a result of the increasing prevalence of heart diseases as well as the growing emphasis on preventive care.

End-use Outlook

On the basis of end-use, the market is divided into patients, providers, payers, and others. The providers segment recorded 21% revenue share in the market in 2023. Hospitals, clinics, and cardiac centers are increasingly adopting digital health tools such as telemedicine platforms, remote patient monitoring systems, and AI-powered diagnostic solutions to provide timely and accurate cardiovascular care.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment garnered 24% revenue share in the market in 2023. Rapid urbanization, changing dietary habits, sedentary lifestyles, and high rates of hypertension and diabetes have increased the demand for digital health solutions targeting heart disease prevention and management.

Digital Health For Cardiovascular Market Coverage:

Report Attribute Details

Market size value in 2023 USD 33.95 Billion

Market size forecast in 2031 USD 162.40 Billion

Base Year 2023

Historical period 2020 to 2022

Forecast Period 2024 to 2031

Revenue Growth Rate CAGR of 21.9% from 2024 to 2031

Number of Pages 182

Tables 270

Report Coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Market Share Analysis, Porter's 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives

Segments Covered Component, End-use, Region

Country Scope * North America (US, Canada, Mexico, and Rest of North America)

Companies Included Apple, Inc., Orange S.A., Epic Systems Corporation, Siemens Healthineers AG (Siemens AG), GE HealthCare Technologies, Inc.. CardiAI.Inc, Vista.ai (HeartVista, Inc.), Viz.ai, Inc., Cleerly, Inc., and RSIP Vision Ltd.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Digital Health For Cardiovascular Market Report Segmentation

By Component

By End-use

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global Digital Health For Cardiovascular Market by Component

Chapter 6. Global Digital Health For Cardiovascular Market by End-use

Chapter 7. Global Digital Health For Cardiovascular Market by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperatives of Digital Health For Cardiovascular Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â